Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study.

Adali, Gupse; Bilgic, Nermin Mutlu; Kalaman, Ahmet Emre; Ozturk, Oguzhan; Ozdil, Kamil

Adali, Gupse; Bilgic, Nermin Mutlu; Kalaman, Ahmet Emre; Ozturk, Oguzhan; Ozdil, Kamil.

Afiliación

Adali G; Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye.
Bilgic NM; Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye.
Kalaman AE; Deparment of Internal Medicine, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye.
Ozturk O; Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye.
Ozdil K; Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye.

Hepatol Forum ; 4(3): 129-134, 2023.

Article en En | MEDLINE | ID: mdl-37822311

Palabras clave

Controlled attenuation parameter score; fatty liver disease; liver transplantation; metabolic-associated fatty liver disease; non-alcoholic fatty liver disease; steatosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Forum Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google